{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T05:04:27Z","timestamp":1775192667281,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T00:00:00Z","timestamp":1420675200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gene Ther"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1038\/gt.2014.116","type":"journal-article","created":{"date-parts":[[2015,1,8]],"date-time":"2015-01-08T11:18:07Z","timestamp":1420715887000},"page":"333-340","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":37,"title":["TGF-\u03b21-siRNA delivery with nanoparticles inhibits peritoneal fibrosis"],"prefix":"10.1038","volume":"22","author":[{"given":"H","family":"Yoshizawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y","family":"Morishita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S","family":"Muto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E","family":"Kusano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2015,1,8]]},"reference":[{"key":"BFgt2014116_CR1","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1177\/089686080002004S03","volume":"20","author":"RT Krediet","year":"2000","unstructured":"Krediet RT, Lindholm B, Rippe B . Pathophysiology of peritoneal membrane failure. Perit Dial Int 2000; 20: S22\u2013S42.","journal-title":"Perit Dial Int"},{"key":"BFgt2014116_CR2","doi-asserted-by":"publisher","first-page":"1201","DOI":"10.1001\/archinte.1980.00330200077024","volume":"140","author":"VC Gandhi","year":"1980","unstructured":"Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow VR, Iwatsuki S et al. Sclerotic thickening of the peritoneal membrane in maintenance peritoneal dialysis patients. Arch Intern Med 1980; 140: 1201\u20131203.","journal-title":"Arch Intern Med"},{"key":"BFgt2014116_CR3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1177\/089686089001000201","volume":"10","author":"C Ronco","year":"1990","unstructured":"Ronco C, Feriani M, Chiaramonte S, Brendolan A, Bragantini L, Conz P et al. Pathophysiology of ultrafiltration in peritoneal dialysis. Perit Dial Int 1990; 10: 119\u2013126.","journal-title":"Perit Dial Int"},{"key":"BFgt2014116_CR4","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1681\/ASN.2009070694","volume":"21","author":"O Devuyst","year":"2010","unstructured":"Devuyst O, Margetts PJ, Topley N . The pathophysiology of the peritoneal membrane. J Am Soc Nephrol 2010; 21: 1077\u20131085.","journal-title":"J Am Soc Nephrol"},{"key":"BFgt2014116_CR5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1177\/089686080302300604","volume":"23","author":"PJ Margetts","year":"2003","unstructured":"Margetts PJ, Bonniaud P . Basic mechanisms and clinical implications of peritoneal fibrosis. Perit Dial Int 2003; 23: 530\u2013541.","journal-title":"Perit Dial Int"},{"key":"BFgt2014116_CR6","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/418244a","volume":"418","author":"GJ Hannon","year":"2002","unstructured":"Hannon GJ . RNA interference. Nature 2002; 418: 244\u2013251.","journal-title":"Nature"},{"key":"BFgt2014116_CR7","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1146\/annurev.genet.36.043002.091619","volume":"36","author":"M Tijsterman","year":"2002","unstructured":"Tijsterman M, Ketting RF, Plasterk RH . The genetics of RNA silencing. Annu Rev Genet 2002; 36: 489\u2013519.","journal-title":"Annu Rev Genet"},{"key":"BFgt2014116_CR8","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1146\/annurev.med.56.082103.104606","volume":"56","author":"DM Dykxhoorn","year":"2005","unstructured":"Dykxhoorn DM, Lieberman J . The silent revolution: RNA interference as basic biology, research tool, and therapeutic. Annu Rev Med 2005; 56: 401\u2013423.","journal-title":"Annu Rev Med"},{"key":"BFgt2014116_CR9","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1182\/blood-2004-12-4643","volume":"106","author":"CA Sledz","year":"2005","unstructured":"Sledz CA, Williams BR . RNA interference in biology and disease. Blood 2005; 106: 787\u2013794.","journal-title":"Blood"},{"key":"BFgt2014116_CR10","doi-asserted-by":"publisher","first-page":"222","DOI":"10.1016\/j.pharmthera.2005.03.004","volume":"107","author":"RK Leung","year":"2005","unstructured":"Leung RK, Whittaker PA . RNA interference: from gene silencing to gene-specific therapeutics. Pharmacol Ther 2005; 107: 222\u2013239.","journal-title":"Pharmacol Ther"},{"key":"BFgt2014116_CR11","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1038\/nrd2310","volume":"6","author":"A de Fougerolles","year":"2007","unstructured":"de Fougerolles A, Vornlocher HP, Maraganore J, Lieberman J . Interfering with disease: a progress report on siRNA-based therapeutics. Nat Rev Drug Discov 2007; 6: 443\u2013453.","journal-title":"Nat Rev Drug Discov"},{"key":"BFgt2014116_CR12","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/nature03121","volume":"432","author":"J Soutschek","year":"2004","unstructured":"Soutschek J, Akinc A, Bramlage B, Charisse K, Constien R, Donoghue M et al. Therapeutic silencing of an endogenous gene by systemic administration of modified siRNAs. Nature 2004; 432: 173\u2013178.","journal-title":"Nature"},{"key":"BFgt2014116_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nature04263","volume":"439","author":"D Palliser","year":"2006","unstructured":"Palliser D, Chowdhury D, Wang QY, Lee SJ, Bronson RT, Knipe DM et al. An siRNA-based microbicide protects mice from lethal herpes simplex virus 2 infection. Nature 2006; 439: 89\u201394.","journal-title":"Nature"},{"key":"BFgt2014116_CR14","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1261\/rna.2192803","volume":"9","author":"SA Stewart","year":"2003","unstructured":"Stewart SA, Dykxhoorn DM, Palliser D, Mizuno H, Yu EY, An DS et al. Lentivirus-delivered stable gene silencing by RNAi in primary cells. RNA 2003; 9: 493\u2013501.","journal-title":"RNA"},{"key":"BFgt2014116_CR15","doi-asserted-by":"publisher","first-page":"e71","DOI":"10.1159\/000142529","volume":"109","author":"Q Yao","year":"2008","unstructured":"Yao Q, Pawlaczyk K, Ayala ER, Styszynski A, Breborowicz A, Heimburger O et al. The role of the TGF\/Smad signaling pathway in peritoneal fibrosis induced by peritoneal dialysis solutions. Nephron Exp Nephrol 2008; 109: e71\u2013e78.","journal-title":"Nephron Exp Nephrol"},{"key":"BFgt2014116_CR16","doi-asserted-by":"publisher","first-page":"1682","DOI":"10.1681\/ASN.2010111197","volume":"22","author":"J Loureiro","year":"2011","unstructured":"Loureiro J, Aguilera A, Selgas R, Sandoval P, Albar-Vizcaino P, Perez-Lozano ML et al. Blocking TGF-beta1 protects the peritoneal membrane from dialysate-induced damage. J Am Soc Nephrol 2011; 22: 1682\u20131695.","journal-title":"J Am Soc Nephrol"},{"key":"BFgt2014116_CR17","first-page":"2219","volume":"125","author":"XJ Li","year":"2012","unstructured":"Li XJ, Sun L, Xiao L, Liu FY . Gene delivery in peritoneal dialysis related peritoneal fibrosis research. Chin Med J (Engl) 2012; 125: 2219\u20132224.","journal-title":"Chin Med J (Engl)"},{"key":"BFgt2014116_CR18","doi-asserted-by":"publisher","first-page":"G143","DOI":"10.1152\/ajpgi.00186.2004","volume":"288","author":"Y Motomura","year":"2005","unstructured":"Motomura Y, Kanbayashi H, Khan WI, Deng Y, Blennerhassett PA, Margetts PJ et al. The gene transfer of soluble VEGF type I receptor (Flt-1) attenuates peritoneal fibrosis formation in mice but not soluble TGF-beta type II receptor gene transfer. Am J Physiol Gastrointest Liver Physiol 2005; 288: G143\u2013G150.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"BFgt2014116_CR19","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1681\/ASN.V133721","volume":"13","author":"PJ Margetts","year":"2002","unstructured":"Margetts PJ, Gyorffy S, Kolb M, Yu L, Hoff CM, Holmes CJ et al. Antiangiogenic and antifibrotic gene therapy in a chronic infusion model of peritoneal dialysis in rats. J Am Soc Nephrol 2002; 13: 721\u2013728.","journal-title":"J Am Soc Nephrol"},{"key":"BFgt2014116_CR20","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1046\/j.1523-1755.2003.00169.x","volume":"64","author":"T Nishino","year":"2003","unstructured":"Nishino T, Miyazaki M, Abe K, Furusu A, Mishima Y, Harada T et al. Antisense oligonucleotides against collagen-binding stress protein HSP47 suppress peritoneal fibrosis in rats. Kidney Int 2003; 64: 887\u2013896.","journal-title":"Kidney Int"},{"key":"BFgt2014116_CR21","doi-asserted-by":"publisher","first-page":"1712","DOI":"10.1038\/sj.gt.3303040","volume":"14","author":"H Guo","year":"2007","unstructured":"Guo H, Leung JC, Chan LY, Tsang AW, Lam MF, Lan HY et al. Ultrasound-contrast agent mediated naked gene delivery in the peritoneal cavity of adult rat. Gene Therapy 2007; 14: 1712\u20131720.","journal-title":"Gene Therapy"},{"key":"BFgt2014116_CR22","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1089\/10430349950018346","volume":"10","author":"A Kikuchi","year":"1999","unstructured":"Kikuchi A, Aoki Y, Sugaya S, Serikawa T, Takakuwa K, Tanaka K et al. Development of novel cationic liposomes for efficient gene transfer into peritoneal disseminated tumor. Hum Gene Ther 1999; 10: 947\u2013955.","journal-title":"Hum Gene Ther"},{"key":"BFgt2014116_CR23","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1038\/nbt1396","volume":"26","author":"Y Sato","year":"2008","unstructured":"Sato Y, Murase K, Kato J, Kobune M, Sato T, Kawano Y et al. Resolution of liver cirrhosis using vitamin A-coupled liposomes to deliver siRNA against a collagen-specific chaperone. Nat Biotechnol 2008; 26: 431\u2013442.","journal-title":"Nat Biotechnol"},{"key":"BFgt2014116_CR24","first-page":"1733","volume":"8","author":"X Wang","year":"2013","unstructured":"Wang X, Podila R, Shannahan JH, Rao AM, Brown JM . Intravenously delivered graphene nanosheets and multiwalled carbon nanotubes induce site-specific Th2 inflammatory responses via the IL-33\/ST2 axis. Int J Nanomedicine 2013; 8: 1733\u20131748.","journal-title":"Int J Nanomedicine"},{"key":"BFgt2014116_CR25","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.toxlet.2012.11.003","volume":"216","author":"M Ban","year":"2013","unstructured":"Ban M, Langonne I, Huguet N, Guichard Y, Goutet M . Iron oxide particles modulate the ovalbumin-induced Th2 immune response in mice. Toxicol Lett 2013; 216: 31\u201339.","journal-title":"Toxicol Lett"},{"key":"BFgt2014116_CR26","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1007\/s00204-012-0823-5","volume":"86","author":"T Morishige","year":"2012","unstructured":"Morishige T, Yoshioka Y, Inakura H, Tanabe A, Narimatsu S, Yao X et al. Suppression of nanosilica particle-induced inflammation by surface modification of the particles. Arch Toxicol 2012; 86: 1297\u20131307.","journal-title":"Arch Toxicol"},{"key":"BFgt2014116_CR27","doi-asserted-by":"publisher","first-page":"1380","DOI":"10.2353\/ajpath.2009.090096","volume":"175","author":"J Li","year":"2009","unstructured":"Li J, Qu X, Bertram JF . Endothelial-myofibroblast transition contributes to the early development of diabetic renal interstitial fibrosis in streptozotocin-induced diabetic mice. Am J Pathol 2009; 175: 1380\u20131388.","journal-title":"Am J Pathol"},{"key":"BFgt2014116_CR28","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1038\/labinvest.3700654","volume":"87","author":"A Bellini","year":"2007","unstructured":"Bellini A, Mattoli S . The role of the fibrocyte, a bone marrow-derived mesenchymal progenitor, in reactive and reparative fibroses. Lab Invest 2007; 87: 858\u2013870.","journal-title":"Lab Invest"},{"key":"BFgt2014116_CR29","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1083\/jcb.122.1.103","volume":"122","author":"A Desmouliere","year":"1993","unstructured":"Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G . Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts. J Cell Biol 1993; 122: 103\u2013111.","journal-title":"J Cell Biol"},{"key":"BFgt2014116_CR30","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/ndt\/gfp480","volume":"25","author":"X Wang","year":"2010","unstructured":"Wang X, Nie J, Jia Z, Feng M, Zheng Z, Chen W et al. Impaired TGF-beta signalling enhances peritoneal inflammation induced by E. coli in rats. Nephrol Dial Transplant 2010; 25: 399\u2013412.","journal-title":"Nephrol Dial Transplant"},{"key":"BFgt2014116_CR31","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1177\/089686080602600317","volume":"26","author":"I Hirahara","year":"2006","unstructured":"Hirahara I, Kusano E, Yanagiba S, Miyata Y, Ando Y, Muto S et al. Peritoneal injury by methylglyoxal in peritoneal dialysis. Perit Dial Int 2006; 26: 380\u2013392.","journal-title":"Perit Dial Int"}],"container-title":["Gene Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/gt2014116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2014116","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/gt2014116.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:13:44Z","timestamp":1648556024000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/gt2014116"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,8]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["BFgt2014116"],"URL":"https:\/\/doi.org\/10.1038\/gt.2014.116","relation":{},"ISSN":["0969-7128","1476-5462"],"issn-type":[{"value":"0969-7128","type":"print"},{"value":"1476-5462","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,8]]},"assertion":[{"value":"30 April 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 November 2014","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2014","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2015","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}